Anastrozoles CAS: 120511-73-1
Inquiry
Post Date: | Aug 21,2015 |
Expiry Date: | Feb 17,2016 |
Detailed Description: |
Anastrozoles CAS: 120511-73-1
email:jaymee at ycphar dot com. Alias: Arimidex CAS No: 120511-73-1 MF: C17H19N5 MW: 293.37 Purity: 98%min Appearance: White crystalline powder. Usage: An aromatase inhibitor. Used as an antineoplastic raw materials. Potent selective triazole aromatase inhibitors, can inhibit the cytochrome P-450 aromatase enzyme which depends blocking the biosynthesis of estrogen, and estrogen to stimulate breast cancer cell growth factors. Treatment of breast cancer, especially for those with hormone relapse after adjuvant therapy after menopause for women with advanced breast cancer. Applications: High Purity Anastrozoles/Arimidex/CAS No: 120511-73-1 The drug is appropriately used when using substantial amounts of aromatizing steroids, or when one is prone to gynecomastia and using moderate amounts of such steroids. Arimidex does not have the side effects of aminoglutethimide (Cytadren) and can achieve a high degree of estrogen blockade, much moreso than Cytadren. It is possible to reduce estrogen too much with Arimidex, and for this reason blood tests, or less preferably salivary tests, should be taken after the first week of use to determine if the dosing is correct. |
Company: | Hubei Yuancheng Saichuang Technology Co., Ltd [ China ] |
Contact: | laukenny |
Tel: | 86-027-50756221 |
Fax: | 86-027-68886696 |
Email: | jaymee@ycphar.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.